Arcadia Biosciences, Inc. (RKDA)
USD 5.87
(-0.51%)
USD 5.87
(-0.51%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.96 Million USD | -18.72% |
| 2022 | 19.55 Million USD | -27.1% |
| 2021 | 26.82 Million USD | 9.83% |
| 2020 | 24.42 Million USD | 18.2% |
| 2019 | 20.66 Million USD | 16.93% |
| 2018 | 17.67 Million USD | -2.13% |
| 2017 | 18.05 Million USD | -13.65% |
| 2016 | 20.91 Million USD | 4.12% |
| 2015 | 20.08 Million USD | -0.26% |
| 2014 | 20.13 Million USD | 23.01% |
| 2013 | 16.37 Million USD | 0.86% |
| 2012 | 16.23 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 3.46 Million USD | -7.83% |
| 2024 Q2 | 2.69 Million USD | -22.19% |
| 2023 Q3 | 3.74 Million USD | -10.89% |
| 2023 Q2 | 4.2 Million USD | -11.47% |
| 2023 FY | 15.89 Million USD | -18.72% |
| 2023 Q1 | 4.75 Million USD | 0.78% |
| 2023 Q4 | 3.75 Million USD | 0.19% |
| 2022 Q1 | 4.74 Million USD | -29.71% |
| 2022 Q2 | 5.01 Million USD | 5.63% |
| 2022 Q3 | 5.09 Million USD | 1.58% |
| 2022 FY | 19.55 Million USD | -27.1% |
| 2022 Q4 | 4.71 Million USD | -7.39% |
| 2021 Q3 | 7.35 Million USD | -2.01% |
| 2021 Q1 | 5.22 Million USD | -22.42% |
| 2021 FY | 26.82 Million USD | 9.83% |
| 2021 Q4 | 6.74 Million USD | -8.18% |
| 2021 Q2 | 7.5 Million USD | 43.48% |
| 2020 Q2 | 5.66 Million USD | -5.03% |
| 2020 FY | 24.42 Million USD | 18.2% |
| 2020 Q4 | 6.73 Million USD | 11.31% |
| 2020 Q3 | 6.05 Million USD | 6.83% |
| 2020 Q1 | 5.96 Million USD | 23.18% |
| 2019 FY | 20.66 Million USD | 16.93% |
| 2019 Q3 | 6.4 Million USD | 25.77% |
| 2019 Q4 | 4.84 Million USD | -24.41% |
| 2019 Q1 | 4.31 Million USD | -5.49% |
| 2019 Q2 | 5.09 Million USD | 18.02% |
| 2018 Q1 | 4.01 Million USD | -8.85% |
| 2018 FY | 17.67 Million USD | -2.13% |
| 2018 Q4 | 4.56 Million USD | 5.13% |
| 2018 Q2 | 4.74 Million USD | 18.07% |
| 2018 Q3 | 4.34 Million USD | -8.39% |
| 2017 FY | 18.05 Million USD | -13.65% |
| 2017 Q1 | 4.87 Million USD | -9.01% |
| 2017 Q2 | 4.61 Million USD | -5.39% |
| 2017 Q3 | 4.16 Million USD | -9.71% |
| 2017 Q4 | 4.4 Million USD | 5.84% |
| 2016 Q1 | 5.63 Million USD | 18.77% |
| 2016 FY | 20.91 Million USD | 4.12% |
| 2016 Q4 | 5.35 Million USD | 8.42% |
| 2016 Q3 | 4.94 Million USD | -0.66% |
| 2016 Q2 | 4.97 Million USD | -11.76% |
| 2015 FY | 20.08 Million USD | -0.26% |
| 2015 Q3 | 5.99 Million USD | 23.12% |
| 2015 Q2 | 4.87 Million USD | 8.97% |
| 2015 Q1 | 4.47 Million USD | 2.45% |
| 2015 Q4 | 4.74 Million USD | -20.84% |
| 2014 Q1 | 3.86 Million USD | -7.51% |
| 2014 Q2 | 6.25 Million USD | 61.79% |
| 2014 Q3 | 5.65 Million USD | -9.72% |
| 2014 FY | 20.13 Million USD | 23.01% |
| 2014 Q4 | 4.36 Million USD | -22.78% |
| 2013 FY | 16.37 Million USD | 0.86% |
| 2013 Q4 | 4.18 Million USD | 47.72% |
| 2013 Q3 | 2.83 Million USD | 21.16% |
| 2013 Q1 | 2.33 Million USD | 0.0% |
| 2013 Q2 | 2.33 Million USD | 0.0% |
| 2012 FY | 16.23 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 136.76 Million USD | 88.325% |
| Muliang Viagoo Technology, Inc. | 2.83 Million USD | -463.044% |
| N2OFF, Inc. | 7.78 Million USD | -105.085% |
| Yield10 Bioscience, Inc. | 14.47 Million USD | -10.299% |